2011
DOI: 10.1186/1471-2407-11-241
|View full text |Cite
|
Sign up to set email alerts
|

A short-term in vivo model for giant cell tumor of bone

Abstract: BackgroundBecause of the lack of suitable in vivo models of giant cell tumor of bone (GCT), little is known about its underlying fundamental pro-tumoral events, such as tumor growth, invasion, angiogenesis and metastasis. There is no existing cell line that contains all the cell and tissue tumor components of GCT and thus in vitro testing of anti-tumor agents on GCT is not possible. In this study we have characterized a new method of growing a GCT tumor on a chick chorio-allantoic membrane (CAM) for this purpo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
46
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(47 citation statements)
references
References 47 publications
(51 reference statements)
1
46
0
Order By: Relevance
“…Stromal cells injected subcutaneously into immunocompromised mice do not produce giant cells (44)(45)(46). Moreover, tumor tissues grown on chick chorioallantoic membranes do not appear to recruit chicken monocytes to synthesize new giant cells and are unsuitable for drug administration, despite increased vascularization from the membrane, but only survive for 10 days (5,31). In our study, we used patient-derived tumor cells isolated from GCTB to establish an orthotopic murine model by intratibial injection.…”
Section: Discussionmentioning
confidence: 99%
“…Stromal cells injected subcutaneously into immunocompromised mice do not produce giant cells (44)(45)(46). Moreover, tumor tissues grown on chick chorioallantoic membranes do not appear to recruit chicken monocytes to synthesize new giant cells and are unsuitable for drug administration, despite increased vascularization from the membrane, but only survive for 10 days (5,31). In our study, we used patient-derived tumor cells isolated from GCTB to establish an orthotopic murine model by intratibial injection.…”
Section: Discussionmentioning
confidence: 99%
“…Advantages are that the CAM model lacks immunological and inflammatory cells, making it an attractive system to avoid effects of the tumor microenvironment interfering with tumor development [6]. This has been used to provide highly reproducible models for glioblastoma [7,8], bone and osteosarcoma [5,9], pancreatic adenocarcinoma [10], ovarian cancer [11], head and neck squamous carcinoma [12], and more recently renal carcinoma [13], as well as CRC [14]. In the last case, the development of CRC and therapeutic escape may be caused by the presence of tumor-initiating cells (TICs) [3,15], which are responsible for driving growth and treatment resistance [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…Spontaneous tumor initiation from human tumor cells grafted Carole Mélin, Aurélie Perraud, Serge Battu and Muriel Mathonnet contributed equally to this work. on the CAM has provided valuable information in a short time regarding such crucial processes as tumor cell proliferation and invasion corresponding to the first steps of carcinogenesis [5]. Advantages are that the CAM model lacks immunological and inflammatory cells, making it an attractive system to avoid effects of the tumor microenvironment interfering with tumor development [6].…”
Section: Introductionmentioning
confidence: 99%
“…On the 5 th day of embryonic development, the CAM attaches to the inner eggshell membrane (Romanoff, 1960) and opening of the egg without rupturing this structure is no longer possible. The procedure was performed as described by Kunzi-Rapp et al (2001) and Balke et al (2011) with a few modifications. Briefly, the eggs were washed with warm (40 ± 5°C) 70% ethanol and placed on a six well plate in horizontal position.…”
mentioning
confidence: 99%